Meticulous records of clonality, phenotypic stability and quality control do more than simply satisfy regulators.
They set an established groundwork for reproducible yield and effective tech transfer from early stage development to large-scale manufacture.
When early data points are justified, scientifically defendable and transparent, everyone wins.
“Robust early data lays the groundwork for reliable biologics manufacturing,” says Brett Verstak, PhD, Head of Cell Line Development at Abzena.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.